# Vivos Therapeutics, Inc.: filings

VVOS · Nasdaq · CIK 1716166 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vvos.md) · [Financials](/companies/vvos/financials.md) · [Filings](/companies/vvos/filings.md) · [Insiders](/companies/vvos/insiders.md)

## Reports and events: 135 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (8-K 85, 4 46, 10-Q 17, CORRESP 16, UPLOAD 13, 3 12, EFFECT 12, S-1 7, S-1/A 7, 10-K 6, DEF 14A 6, NT 10-Q 6, SC 13G/A 6, 424B1 5, 424B5 5, SCHEDULE 13G 5, DEFA14A 4, S-3 4, SC 13G 4, 424B3 3, 424B4 3, D 3, SCHEDULE 13D 3, 8-K/A 2, DRS 2, PRE 14A 2, S-1MEF 2, S-3/A 2, SCHEDULE 13G/A 2, 10-K/A 1, 10-Q/A 1, 3/A 1, 5 1, 8-A12B 1, CERT 1, D/A 1, NT 10-K 1, POS AM 1, PRER14A 1, S-8 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-29 | 15:55 ET | [DEF 14A](/filings/0001493152-26-049258.md) | Proxy statement, period 2026-10-29 | 0001493152-26-049258 |
| 2026-10-21 | 07:00 ET | [8-K](/filings/0001493152-26-047841.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-047841 |
| 2026-10-19 | 16:49 ET | [8-K](/filings/0001493152-26-047601.md) | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-047601 |
| 2026-10-15 | 08:45 ET | [8-K](/filings/0001493152-26-047158.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-047158 |
| 2026-10-01 | 21:54 ET | [8-K](/filings/0001493152-26-045193.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-26-045193 |
| 2026-09-08 | 17:29 ET | [8-K/A](/filings/0001493152-26-041807.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-041807 |
| 2026-09-08 | 18:26 ET | [8-K](/filings/0001493152-26-041616.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-041616 |
| 2026-08-21 | 17:30 ET | [8-K](/filings/0001493152-26-039736.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-039736 |
| 2026-08-14 | 16:07 ET | [10-Q](/filings/0001493152-26-038336.md) | Quarterly report, period 2026-06-30 | 0001493152-26-038336 |
| 2026-08-11 | 17:02 ET | [8-K](/filings/0001493152-26-037173.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-037173 |
| 2026-08-03 | 17:29 ET | [8-K](/filings/0001493152-26-035867.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-035867 |
| 2026-07-15 | 17:07 ET | [SCHEDULE 13D](/filings/0001104659-26-083931.md) | Ownership report, active investor | 0001104659-26-083931 |
| 2026-07-07 | 17:29 ET | [8-K](/filings/0001493152-26-032387.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-26-032387 |
| 2026-06-25 | 17:22 ET | [8-K](/filings/0001493152-26-030190.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-030190 |
| 2026-06-16 | 17:03 ET | [8-K](/filings/0001493152-26-028912.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-028912 |
| 2026-06-16 | 19:44 ET | [8-K](/filings/0001493152-26-028775.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-028775 |
| 2026-06-08 | 08:30 ET | [8-K](/filings/0001493152-26-027641.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.01 Delisting notice; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-027641 |
| 2026-05-20 | 17:05 ET | [10-Q](/filings/0001493152-26-024650.md) | Quarterly report, period 2026-03-31 | 0001493152-26-024650 |
| 2026-04-22 | 16:25 ET | [8-K](/filings/0001493152-26-018562.md) | 3.01 Delisting notice | 0001493152-26-018562 |
| 2026-04-15 | 17:15 ET | [8-K](/filings/0001493152-26-016865.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-26-016865 |
| 2026-04-15 | 17:00 ET | [10-K](/filings/0001493152-26-016854.md) | Annual report, period 2025-12-31 | 0001493152-26-016854 |
| 2026-04-03 | 16:05 ET | [8-K](/filings/0001493152-26-015132.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-015132 |
| 2026-04-02 | 18:32 ET | [SCHEDULE 13D](/filings/0001104659-26-039298.md) | Ownership report, active investor | 0001104659-26-039298 |
| 2026-02-06 | 16:05 ET | [8-K](/filings/0001493152-26-005554.md) | 5.02 Departure or appointment of officers or directors | 0001493152-26-005554 |
| 2026-01-20 | 16:05 ET | [8-K](/filings/0001493152-26-002844.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-002844 |
| 2026-01-16 | 16:05 ET | [8-K](/filings/0001493152-26-002557.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-26-002557 |
| 2025-12-17 | 17:54 ET | [8-K](/filings/0001493152-25-028019.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-028019 |
| 2025-12-05 | 17:12 ET | [8-K](/filings/0001493152-25-026438.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001493152-25-026438 |
| 2025-11-19 | 16:45 ET | [8-K](/filings/0001493152-25-024289.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001493152-25-024289 |
| 2025-11-19 | 16:06 ET | [10-Q](/filings/0001493152-25-024253.md) | Quarterly report, period 2025-09-30 | 0001493152-25-024253 |
| 2025-11-04 | 16:58 ET | [8-K](/filings/0001493152-25-020750.md) | 5.07 Shareholder vote results | 0001493152-25-020750 |
| 2025-10-24 | 17:20 ET | [8-K](/filings/0001493152-25-019359.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-019359 |
| 2025-09-29 | 19:42 ET | [DEF 14A](/filings/0001493152-25-015837.md) | Proxy statement, period 2025-09-26 | 0001493152-25-015837 |
| 2025-09-18 | 20:41 ET | [8-K](/filings/0001493152-25-013953.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-013953 |
| 2025-09-12 | 16:52 ET | [8-K](/filings/0001641172-25-027210.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-027210 |
| 2025-08-25 | 16:46 ET | [8-K/A](/filings/0001641172-25-025396.md) | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-025396 |
| 2025-08-20 | 16:05 ET | [8-K](/filings/0001641172-25-024979.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-024979 |
| 2025-08-19 | 16:06 ET | [10-Q](/filings/0001641172-25-024832.md) | Quarterly report, period 2025-06-30 | 0001641172-25-024832 |
| 2025-06-16 | 19:57 ET | [SCHEDULE 13D](/filings/0002049575-25-000002.md) | Ownership report, active investor | 0002049575-25-000002 |
| 2025-06-13 | 17:02 ET | [8-K](/filings/0001641172-25-015115.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-015115 |
| 2025-06-06 | 17:19 ET | [8-K](/filings/0001641172-25-014118.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-014118 |
| 2025-05-23 | 08:00 ET | [8-K](/filings/0001641172-25-012181.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001641172-25-012181 |
| 2025-05-15 | 17:25 ET | [8-K](/filings/0001641172-25-011084.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-011084 |
| 2025-05-15 | 16:05 ET | [10-Q](/filings/0001641172-25-010874.md) | Quarterly report, period 2025-03-31 | 0001641172-25-010874 |
| 2025-04-17 | 08:30 ET | [8-K](/filings/0001641172-25-005165.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001641172-25-005165 |
| 2025-03-31 | 17:29 ET | [8-K](/filings/0001641172-25-001895.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001641172-25-001895 |
| 2025-03-31 | 16:20 ET | [10-K](/filings/0001641172-25-001750.md) | Annual report, period 2024-12-31 | 0001641172-25-001750 |
| 2025-02-14 | 07:55 ET | [8-K](/filings/0001493152-25-006584.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-25-006584 |
| 2025-01-29 | 06:04 ET | [S-1/A](/filings/0001493152-25-004057.md) | Registration statement, amended | 0001493152-25-004057 |
| 2025-01-22 | 06:09 ET | [S-1](/filings/0001493152-25-003115.md) | Registration statement | 0001493152-25-003115 |

Page 1 of 3. [Older](/companies/vvos/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 2, 2026, 06:07 ET. No prices; not investment advice.